Abstract
The interaction of three novel synthesized complexes of [Pd(phen)(R-gly)]NO3, where R-gly is methyl-, propyl-, and amyl-glycine; and phen is 1,10-phenanthroline were synthesized and characterized by spectroscopic methods. The interaction of ct-DNA with different concentrations of these palladium(II) complexes were studied by UV–Vis, fluorescence, circular dichroism spectroscopy, viscometric, and voltammetric measurements in Tris–HCl buffer solution containing 10mM sodium chloride (pH 7.2) at 27 and 37°C as well as molecular dynamics (MD) simulation and molecular docking. The biological activity of the synthesized Pd(II) complexes was tested against chronic myelogenous leukemia cell line K562 at micromolar concentrations. Binding constants obtained by UV–Vis spectroscopy for methyl, propyl and amyl derivatives are as 5.08×105, 5.55×105, 7.08×105 at 27°C and 5.53×105, 6.54×105, 10.01×105M−1 at 37°C, respectively. The experimental results suggested that these complexes cooperatively bind to DNA presumably via intercalation. Moreover, these Pd(II) complexes showed higher tendency to interact with DNA at higher concentrations and temperatures. These Pd complexes increase the Tm, viscosity, and helicity of DNA solution. The binding data shows that methyl-derivative has higher tendency for binding to DNA. The trend of changes in the structural parameters such as calculated ASA, RMSD, hydrogen bond, and experimental viscosity were amyl>propyl>methyl. The results suggest that the synthesized Pd(II) complexes have dose–response suppression on growing of K562 leukemia cell line. Also, according to Cc50 values, it is clear that the Pd(II) complex of methylglycine has higher cytotoxic or anti-proliferative effect against K562 leukemia cell line.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.